Total Payments
$28,232
2024 Payments
$4,034
Companies
41
Transactions
649
Medicare Patients
12,575
Medicare Billing
$1.4M
Payment Breakdown by Category
Food & Beverage$26,795 (94.9%)
Travel$1,357 (4.8%)
Education$80.99 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $26,795 | 641 | 94.9% |
| Travel and Lodging | $1,357 | 3 | 4.8% |
| Education | $80.99 | 5 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $3,303 | 84 | $0 (2024) |
| Medtronic, Inc. | $2,595 | 27 | $0 (2024) |
| Boston Scientific Corporation | $2,361 | 47 | $0 (2024) |
| ATRICURE, INC. | $2,145 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,885 | 61 | $0 (2024) |
| PFIZER INC. | $1,825 | 90 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,617 | 20 | $0 (2024) |
| Medtronic Vascular, Inc. | $1,465 | 15 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $1,290 | 45 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,072 | 35 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,034 | 113 | Janssen Pharmaceuticals, Inc ($604.25) |
| 2023 | $6,654 | 124 | ATRICURE, INC. ($1,829) |
| 2022 | $3,287 | 93 | Medtronic, Inc. ($646.62) |
| 2021 | $3,553 | 90 | BOSTON SCIENTIFIC CORPORATION ($570.14) |
| 2020 | $2,381 | 68 | Janssen Pharmaceuticals, Inc ($510.33) |
| 2019 | $3,314 | 69 | Medtronic Vascular, Inc. ($717.62) |
| 2018 | $2,169 | 45 | Janssen Pharmaceuticals, Inc ($467.17) |
| 2017 | $2,841 | 47 | Novartis Pharmaceuticals Corporation ($666.29) |
All Payment Transactions
649 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.16 | General |
| Category: DIABETES | ||||||
| 12/19/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Cardiology | ||||||
| 12/13/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $29.23 | General |
| Category: Genetic Disease | ||||||
| 12/07/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $25.66 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/05/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $28.70 | General |
| Category: Cardiology | ||||||
| 12/02/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $29.83 | General |
| Category: Cardiology | ||||||
| 11/25/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: Cardiology | ||||||
| 11/22/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $29.22 | General |
| Category: Cardiovascular | ||||||
| 11/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $30.27 | General |
| Category: Cardio-renal | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $27.73 | General |
| Category: Cardiovascular | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2024 | ATRICURE, INC. | SYNERGY ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $141.16 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/11/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/08/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $30.95 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $29.26 | General |
| Category: Cardiology | ||||||
| 10/31/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $28.31 | General |
| Category: Transcatheter Heart Valves | ||||||
| 10/29/2024 | Boston Scientific Corporation | ACCOLADE SR (Device) | Food and Beverage | In-kind items and services | $146.39 | General |
| Category: ACCOLADE_CRM | ||||||
| 10/28/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/28/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $0.54 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/21/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/14/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 3,335 | 5,516 | $1.2M | $383,644 |
| 2022 | 18 | 2,987 | 5,086 | $1.2M | $359,007 |
| 2021 | 17 | 3,196 | 4,905 | $790,770 | $370,517 |
| 2020 | 19 | 3,057 | 4,606 | $806,178 | $335,857 |
Total Patients
12,575
Total Services
20,113
Medicare Billing
$1.4M
Procedure Codes
77
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 411 | 1,220 | $352,919 | $87,450 | 24.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 455 | 526 | $205,200 | $62,331 | 30.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 260 | 515 | $125,265 | $59,119 | 47.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 101 | 102 | $83,342 | $42,135 | 50.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 158 | 159 | $62,032 | $28,906 | 46.6% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 101 | 204 | $51,500 | $19,251 | 37.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 251 | 259 | $46,879 | $15,481 | 33.0% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 68 | 276 | $82,800 | $12,350 | 14.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 64 | 64 | $24,364 | $9,474 | 38.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 697 | 1,143 | $28,575 | $8,248 | 28.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 68 | 144 | $9,016 | $6,562 | 72.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 286 | 468 | $13,809 | $6,233 | 45.1% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 102 | 103 | $13,182 | $5,811 | 44.1% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 17 | 17 | $25,296 | $4,693 | 18.6% |
| 96374 | Injection of drug or substance into vein | Office | 2023 | 101 | 102 | $9,517 | $3,589 | 37.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 20 | $4,664 | $3,285 | 70.4% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 16 | 16 | $4,947 | $2,902 | 58.7% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 12 | 12 | $3,666 | $2,205 | 60.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 14 | 20 | $4,040 | $1,222 | 30.2% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 71 | 72 | $2,627 | $1,054 | 40.1% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 11 | 11 | $1,438 | $748.44 | 52.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 34 | 44 | $792.52 | $369.60 | 46.6% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 19 | 19 | $2,455 | $224.58 | 9.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 491 | 1,523 | $474,650 | $101,387 | 21.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 571 | 658 | $262,915 | $84,034 | 32.0% |
About Rakesh Gupta
Rakesh Gupta is a Cardiovascular Disease healthcare provider based in Queens Village, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2007. The National Provider Identifier (NPI) number assigned to this provider is 1922144302.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Rakesh Gupta has received a total of $28,232 in payments from pharmaceutical and medical device companies, with $4,034 received in 2024. These payments were reported across 649 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($26,795).
As a Medicare-enrolled provider, Gupta has provided services to 12,575 Medicare beneficiaries, totaling 20,113 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Queens Village, NY
- Active Since 01/30/2007
- Last Updated 04/08/2008
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1922144302
Products in Payments
- XARELTO (Drug) $3,303
- ELIQUIS (Drug) $2,214
- ENTRESTO (Drug) $1,601
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) $1,526
- JARDIANCE (Drug) $1,520
- VERQUVO (Drug) $897.58
- Ozempic (Drug) $834.09
- WATCHMAN (Device) $809.03
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $759.74
- COBALT DR MRI SURESCAN (Device) $752.74
- FARXIGA (Drug) $623.88
- Repatha (Biological) $561.30
- LifeVest (Device) $522.87
- Claria MRI (Device) $511.62
- BRILINTA (Drug) $486.50
- GORE CARDIOFORM Septal Occluder (Device) $381.40
- Resolute (Device) $374.36
- LINQ II (Device) $358.46
- WATCHMAN Access System (Device) $357.10
- VYNDAQEL (Drug) $316.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Queens Village
Dr. Manuel Lopez, M.d, M.D
Cardiovascular Disease — Payments: $32,784
Cardiovascular Disease $32,784
Sanjiv Singal, Md, Facc, MD, FACC
Cardiovascular Disease — Payments: $1,381
Cardiovascular Disease $1,381
Obi Nwasokwa, M.d, M.D
Cardiovascular Disease — Payments: $149.57
Cardiovascular Disease $149.57